510(k) device
OMNI Surgical System
Sight Sciences, Inc. · Pump, Infusion, Ophthalmic (MRH, Class II) · First FDA decision Dec 21, 2017, newest Aug 25, 2023Glaucoma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
39
Naming "OMNI"
MAUDE reports
1,904
Brand "OMNI", since 2015
PubMed studies
1,728
Mentioning "OMNI"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing OMNI Surgical System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- OMNI Surgical System510(k)
K232214 · Decided Aug 25, 2023 · 30 days after receipt
Device type: Pump, Infusion, Ophthalmic (MRH) · Hospital Medicine & Nursing
- OMNI Surgical System510(k)
K202678 · Decided Mar 1, 2021 · 167 days after receipt
Device type: Pump, Infusion, Ophthalmic (MRH) · Hospital Medicine & Nursing
- OMNI Surgical System510(k)
K173332 · Decided Dec 21, 2017 · 59 days after receipt
Device type: Pump, Infusion, Ophthalmic (MRH) · Hospital Medicine & Nursing
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "OMNI", any status and sponsor, newest update first.
- OMNI 3.1 Surgical System in Subjects With Primary Open-Angle GlaucomaActive, not recruiting
Sight Sciences, Inc.Not on our public-company list
NCT06991270 · 25 participants (planned) · Start Oct 8, 2025 · Primary completion Dec 1, 2026
Device: OMNI 3.0 Surgical System · For: Primary Open Angle Glaucoma
Sites: Panama City, Panama
Nova Scotia Health AuthorityAcademic, hospital or other
NCT06495450 · 30 participants (planned) · Start Apr 28, 2025 · Primary completion Aug 6, 2027
Device: Omnidirectional Virtual Reality and Treadmill Training · For: Stroke
Sites: Halifax, Canada
GE HealthcarePublic (GEHC)
NCT07857161 · 60 participants (planned) · Start Sep 15, 2026 · Primary completion Mar 1, 2027
Device: Omni 128cm PET/CT · For: PET/CT
Sites: Stanford, California
36 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "OMNI", and for the whole product code for context.
This brand
1,904 reports: 1,404 malfunction, 485 injury, 10 death
Whole product code MRH
140 reports: 44 malfunction, 95 injury, 0 death
Newest reports for this brand
- AngioJet SOLENT omniMalfunction
2124215-2026-55339 · Received Oct 19, 2026 · Event dated Sep 1, 2026
Device type: Catheter, Embolectomy (DXE)
Device problem as coded: Contamination
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Omni HysteroscopeMalfunction
1222780-2026-00789 · Received Oct 15, 2026 · Event dated Oct 6, 2026
Device type: Hysteroscope (And Accessories) (HIH)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- AngioJet SOLENT omniMalfunction
2124215-2026-53710 · Received Oct 9, 2026 · Event dated Sep 10, 2026
Device type: Catheter, Embolectomy (DXE)
Device problem as coded: Break; Deformation Due to Compressive Stress
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "OMNI"[tiab]. The summary above synthesizes these.
- Omni-local consciousness.
Lohrey A, Boreham B · Commun Integr Biol · 2022
- An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues.
Corces MR, Trevino AE, Hamilton EG, et al. · Nat Methods · 2017
- Omni-Training: Bridging Pre-Training and Meta-Training for Few-Shot Learning.
Shu Y, Cao Z, Gao J, et al. · IEEE Trans Pattern Anal Mach Intell · 2023
- Omni-resonant optical micro-cavity.
Shabahang S, Kondakci HE, Villinger ML, et al. · Sci Rep · 2017Research Support, U.S. Gov't, Non-P.H.S.
- X-ray omni microscopy.
Paganin D, Gureyev TE, Mayo SC, et al. · J Microsc · 2004Research Support, Non-U.S. Gov't
- Omni-polarized Faraday isolator based on non-Hermitian Faraday system.
Hu H, Fu X, Qi J, et al. · Opt Express · 2024
- Omni-dimensional dynamic convolution feature coordinate attention network for pneumonia classification.
Li Y, Xin Y, Li X, et al. · Vis Comput Ind Biomed Art · 2024
- Development of Omni InDel and supporting database for maize.
Liu Z, Zhao Y, Zhang Y, et al. · Front Plant Sci · 2023
- Deep Omni-Supervised Learning for Rib Fracture Detection From Chest Radiology Images.
Chai Z, Luo L, Lin H, et al. · IEEE Trans Med Imaging · 2024Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- An Omni-Mesoscope for multiscale high-throughput quantitative phase imaging of cellular dynamics and high-content molecular characterization.
Ma H, Chen M, Xu J, et al. · Sci Adv · 2024Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- HTT-OMNI: A Web-based Platform for Huntingtin Interaction Exploration and Multi-omics Data Integration.
Kennedy MA, Greco TM, Song B, et al. · Mol Cell Proteomics · 2022Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
- Bilayer Intelligent Omni-Surface-Assisted Full-Duplex Systems: Simultaneous Self-Interference Cancellation and Sum Rate Maximization.
Zhou Y, Wu Q, Zhu Y · Sensors (Basel) · 2024
Other devices of this type
Also filed under product code MRH.
- Viscoelastic InjectorSight Sciences, Inc. · 510(k) 2014
- OMNI Ultra Surgical System (1-110)Sight Sciences, Inc. · 510(k) 2026
- VIA360 Surgical SystemNew World Medical, Inc. · 510(k) 2025
- TrabEx ProMicrosurgical Technologies, Inc. · 510(k) 2022
- iPrime Viscodelivery SystemGlaukos · 510(k) 2022
- Streamline Surgical SystemNew World Medical, Inc. · 510(k) 2021
- OMNI PLUS Surgical SystemSight Sciences, Inc. · 510(k) 2020
- VISCO 360 Viscosurgical SystemSight Sciences, Inc. · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.